Trial Profile
Phase 1 study of GLPG2938 in patients with idiopathic pulmonary fibrosis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs GLPG 2938 (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions
- 20 Jun 2016 New trial record
- 15 Jun 2016 According to Galapagos media release, this study is expected to start in 2017.